Skip to main content
Critical Care logoLink to Critical Care
letter
. 2019 Feb 8;23:35. doi: 10.1186/s13054-019-2333-9

Is fluid resuscitation the “Keyser Soze” of acute kidney injury in trauma patients?

Matthieu Jamme 1,2,3,, Omar Ben Hadj Salem 1
PMCID: PMC6367830  PMID: 30736819

Dear Editor,

We read with great interest the study of Harrois et al. [1] that assessed the prevalence and risk factors of acute kidney injury (AKI) in trauma patients. In this large cohort, AKI was frequently observed, especially in patients admitted with hemorrhagic shock (42.5%) and was associated with hypoperfusion markers (blood lactate, minimum prehospital mean arterial pressure, maximum prehospital heart rate) and severity of trauma (hemorrhagic shock and higher Injury Severity Score). Interestingly, patients who required vasopressors did not develop more AKI, suggesting that in addition to renal ischemia, many different physiopathological pathways may be involved in AKI.

Due to these results, the authors have logically suggested systemic inflammation, rhabdomyolysis, renal parenchyma injuries, and ischemic tubulopathy as possible mechanisms leading to AKI. However, information concerning fluid administration during prehospital and hospital periods were not mentioned.

Although the use of colloids was recently restricted in the last European guidelines, due to hemostatic effects, for the benefit of crystalloids solutions [2], it is now well known that colloids are also nephrotoxic due to an accumulation of lysosomes in proximal tubular cells, also called osmotic nephrosis [3]. However, an excess of 0.9% NaCl solution administration causes hyperchloremia, a powerful vasoconstrictor agent of glomerular afferent arterioles and, i.e., a potential factor to extend renal ischemia [4]. Consequently, guidelines suggest to not use more than 1500 mL of 0.9% NaCl solution [2]. In case of head trauma, in which hypotonic solution should be avoided, fluid resuscitation becomes tricky.

Several promising studies had recently identified new potential therapeutic agents of ischemic tubulopathy [5] or rhabdomyolysis, which highlight the need for early identification of mechanisms underlying AKI.

In their report, the authors did not provide data concerning the volume of crystalloid administration, volume of colloid perfused, and indirect biomarker of a high infusion of crystalloid (high base deficit, hyperchloremia) or colloid (hypocalcemia). We hypothesize that these variables are possibly implicated with AKI following major bleeding.

Acknowledgments

Funding

Not applicable

Availability of data and materials

Not applicable

Authors’ contributions

MJ drafted the manuscript. OBHS helped to draft the manuscript. Both authors read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Footnotes

References

  • 1.Harrois A, Soyer B, Gauss T, Hamada S, Raux M, Duranteau J, et al. Prevalence and risk factors for acute kidney injury among trauma patients: a multicenter cohort study. Crit Care Lond Engl. 2018;22(1):344. doi: 10.1186/s13054-018-2265-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20(1):100. doi: 10.1186/s13054-016-1265-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Schortgen F, Brochard L. Colloid-induced kidney injury: experimental evidence may help to understand mechanisms. Crit Care. 2009;13(2):130. doi: 10.1186/cc7745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest mars. 1983;71(3):726–735. doi: 10.1172/JCI110820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Katsyuba E, Mottis A, Zietak M, De Franco F, van der Velpen V, Gariani K, et al. De novo NAD+ synthesis enhances mitochondrial function and improves health. Nature. 2018;563(7731):354–359. doi: 10.1038/s41586-018-0645-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Not applicable


Articles from Critical Care are provided here courtesy of BMC

RESOURCES